moxisylyte has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, R | 1 |
| Sugihara, I | 1 |
| Kurimoto, S | 1 |
1 other study available for moxisylyte and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effect of moxisylyte hydrochloride (alpha 1-blocker) on the retinal circulation of patients with diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Blood Circulation; Diabetes Mellitus, Type 1; Diabetes Mellitus, | 1992 |